TAGRISSO® (osimertinib) HCP

Please see full Important Safety Information below in the pinned post and at www.tagrissohcp.com/#isi This product information is intended for US Healthcare Professionals only. TAGRISSO is an AstraZeneca brand and is not associated with any individual users on LinkedIn. Please see full Prescribing Information including Patient Information by visiting tagrissohcp.az/piFB You may report side effects related to AstraZeneca products by visiting https://us-aereporting.astrazeneca.com/adverse-events.html US-68753 Last Updated 10/22